Connecting Australia’s chemistry researchers with the global bioscience research community.

Compounds Australia provides access to critical infrastructure and expertise to ensure flexible, efficient, reproducible and cost-effective compound management, supporting biological characterisation of compounds throughout the drug discovery pipeline.
Compounds Australia is part of the Griffith Institute for Drug Discovery (GRIDD). GRIDD tackles devastating diseases using the unique Compounds Australia and NatureBank resources, and an extensive global network of partners.
Our libraries
Compounds Australia securely stores and curates sample libraries submitted by Australian based chemists. The facility makes these compounds available at low cost in flexible screening and assay-ready formats to academic and not-for-profit researchers.

iLab
iLab Operations Software, is an enterprise web-based management tool designed to support operations for centralized labs and shared research resources. Its functionality includes service request and milestone management, sample processing, equipment reservation management, usage tracking, and lab requisitioning. Contact us to generate an account.

CASPeR
Compounds Australia Structure Portal was launched in early 2016 and enables researchers to browse or search the ‘Open’ Compound Collections via a web portal.
CASPeR provides researchers with access to up to date information such as individual chemical properties.

Membership
Membership of Compounds Australia is at an organisational level. Being a member of Compounds Australia enables you to access a wide range of services hosted by the facility.
Our services
Compounds Australia provides access to critical infrastructure and expertise to ensure flexible, efficient, reproducible and cost-effective compound management supporting biological characterisation of compounds throughout the drug discovery pipeline.
Testimonial
"Communication from Compounds Australia was extremely efficient and unambiguous. Importantly, after the primary screen concluded and the end user was looking to validate the key targets, Compounds Australia went above and beyond to identify solutions to a major problem we faced in sourcing sufficient reagents. Without their diligence and commitment, this project would not have been completed as originally anticipated."
Associate Professor Kaylene J. Simpson, Head, Victorian Centre for Functional Genomics
